Directions: Use on affected areas. Make sure the affected area is dry before use. If you are using a moisturizer, use Tazarodex Cream at least 1 hour after applying the moisturizer to the affected area. Avoid sun exposure after applying Tazarodex Cream as it will make your skin more sensitive to UV rays for 6 hours. Spread it evenly and avoid excessive application. For best results, use only nights or as directed ...
Other information: Store at controlled room temperature 59-86°F
www.psodexusa.comPsoriasis is a chronic disease that often comes and goes.
Acne is a common skin condition that can fluctuate over time.
The main goal of treatment is to manage symptoms.
PSODEX Tazarodex Cream offers a soothing formula that helps block the recurrence of plaque psoriasis & acne vulgaris symptoms with the effect of SALICYLIC ACID, UREA, and TAZARATONE.
The main goal of treatment is to manage symptoms.
PREVENTS:
Excessive skin cell growth
RELIEVES:
Itching, inflammation, and roughness
CONTROLS:
Flaking, scaling, and excessive sebum secretion
HELPS BLOCK:
Recurrence of psoriasis and acne symptoms
Inactive Ingredients:
Aloe Barbadensis Leaf Extract, Allantoin, a-Bisabolol,Benzoic Acid, Cetyl Alcohol, Dehydroacetic Acid, Di-C12-13 Alkyl Malate, Dipropylene Glycol, Distilled Water, Glyceryl Monostearate, Laureth-9, Mentha Piperita Extract, Octyldodecanol, Panthenol, Paraffinum Liquidum, Phenoxyethanol, Salicylic Acid, Urea, Xanthan Gum
Use:
Controls symptoms of plaque psoriasis, acne vulgaris
DISTRIBUTED BY: Psodex USA Inc.
9898 Bissonnet St Ste 625 Houston, TX 77036
1-844 4PSODEX www.psodexusa.com
MANUFACTURED FOR
Yesim Derma Laboratories
Directions:
Use on affected areas. Make sure the affected area is dry before use. If you are using a moisturizer, use Tazarodex Cream at least
1 hour after applying the moisturizer to the affected area. Avoid sun exposure after applying Tazarodex Cream as it will make your
skin more sensitive to UV rays for 6 hours. Spread it evenly and avoid excessive application. For best results, use only nights or as
directed by a doctor.
Active ingredient:
Tazarotene 0.1%
Ask a doctor before use if
You have a history of skin sensitivity to topical products or have any medical conditions that affect your skin.
Do not use:
Keep out of reach of children: If swallowed, get medical help or contact a Poison Control Center right away.
Purpose:
Plaque Psoriasis & Acne
Questions or Comments: 1 844 4PSODEX | info@psodexusa.com
Stop use and ask a doctor if
Excessive skin irritation/allergic reaction occurs, condition worsens or does not improve after regular use of this product as directed.
When using this product:
Other information:
Store at controlled room temperature 59-86°F
Warnings: For external use only
Tazarotene 0.1%
| Class | Version | Type | Effective |
|---|---|---|---|
| TAZAROTENE Pharmacologic Class Indexing | 2 | Indexing - Pharmacologic Class | 20180813 |
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| a107c35c-2cb4-4734-a92b-e9ed5cfc34d6 | Product name | 2 | 20260220 |
| 5993ea1b-833d-fa4b-caad-a0d477537538 | Product name | 5 | 20250305 |
| c24b0f4e-b27e-8e2b-a129-1b5a6d72c459 | Product name | 2 | 20231128 |
| 2d2ef081-4f0c-4669-81e8-32b263669a0a | Product name | 1 | 20230801 |
| c6f86816-7da6-43ea-8c25-ac9758311cc5 | Product name | 1 | 20220118 |
| 18da2240-e326-4d63-90cd-d6bb15f662a0 | Product name | 1 | 20200604 |
| dea2eded-d1e7-46bb-9a3d-f8dc20de6277 | Product name | 1 | 20190408 |
| 252e11b6-1a9a-4283-a242-df2c129c496d | Product name | 3 | 20170717 |
| a32b252c-8cd2-cc4a-c64c-4b9d3916df9e | Product name | 1 | 20140508 |
| af534dc0-c9e5-19a6-693c-e7ad53714660 | Product name | 1 | 20140508 |
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 73503-007-00 | TazarodexPlaque Psoriasis and Acne | 1000 mL in 1 BOTTLE, PUMP | CREAM | 1000 | 3 | |
| 73503-007-01 | TazarodexPlaque Psoriasis and Acne | 1000 in 1 BOX | CREAM | 1000 | 3 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 73503-007 | 73503-007-00, 73503-007-01 |
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| SALICYLIC ACID | O414PZ4LPZ | IACT |
| DEHYDROACETIC ACID | 2KAG279R6R | IACT |
| DI-C12-13 ALKYL MALATE | RRL7C51WPD | IACT |
| MINERAL OIL | T5L8T28FGP | IACT |
| CETYL ALCOHOL | 936JST6JCN | IACT |
| XANTHAN GUM | TTV12P4NEE | IACT |
| ALLANTOIN | 344S277G0Z | IACT |
| POLIDOCANOL | 0AWH8BFG9A | IACT |
| MENTHA PIPERITA LEAF | A389O33LX6 | IACT |
| DIPROPYLENE GLYCOL | E107L85C40 | IACT |
| GLYCERYL MONOSTEARATE | 230OU9XXE4 | IACT |
| PANTHENOL | WV9CM0O67Z | IACT |
| BENZOIC ACID | 8SKN0B0MIM | IACT |
| OCTYLDODECANOL | 461N1O614Y | IACT |
| PHENOXYETHANOL | HIE492ZZ3T | IACT |
| UREA | 8W8T17847W | IACT |
| LEVOMENOL | 24WE03BX2T | IACT |
| TAZAROTENE | 81BDR9Y8PS | ACTIB |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| 0d0ed130-0851-4fac-e063-6394a90ac1dc | 02f948ad-4037-7b63-e063-6394a90a737e | 2023-12-21 | Warnings | 0d0ed130-0851-4fac-e063-6394a90ac1dc 02f948ad-4037-7b63-e063-6394a90a737e |
Adverse event summaries are temporarily unavailable. Other product information remains available.